The transplantation of hemopoietic progenitors in chronic myeloid leukemia: why, how and when?
Tomás, J.F.; Fernández-Rañada, J.M.
Medicina Clinica 104(17): 653-655
1995
ISSN/ISBN: 0025-7753 PMID: 7623492 Document Number: 441738
Document emailed within 1 workday
Related Documents
Baccarani, M. 1998: SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768 Leukemia 12(7): 1168-1170Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Naganuma, K.; Ishii, E.; Ishiguro, A.; Ando, O.; Tsuji, K.; Yagi, Y.; Norose, N.; Koike, K.; Nakahata, T.; Akabane, T. 1986: Hemopoietic progenitors before and after bone marrow transplantation Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(4): 852-861
Rabella García, N.; Brunet Mauri, S.; Navarro Risueño, F.; Sureda Balari, A. 1998: Allogeneic hemopoietic progenitors transplantation and adenovirus infection Medicina Clinica 111(4): 159
Tanaka, T.; Tanaka, K.; Ogawa, S.; Kurokawa, M.; Mitani, K.; Nishida, J.; Shibata, Y.; Yazaki, Y.; Hirai, H. 1995: An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms EMBO Journal 14(2): 341-350
Fernández-Avilés, F.; Ribera, J.M.; Batlle, M.; Lauzurica, R. 1997: Chronic myeloid leukemia after kidney transplantation Sangre 42(1): 85-86
Klingemann, H.G.; Deeg, H.J.; Storb, R. 1985: Bone marrow transplantation in chronic myeloid leukemia Deutsche Medizinische Wochenschrift 110(1): 37-38
Gruss, E.; Tomás, J.F.; Bernis, C.; Rodríguez, F.; Traver, J.A.; Fernández-Rañada, J.M. 1998: Acute renal failure in the allogeneic transplantation of hemopoietic progenitors. the clinical characteristics in a series of 92 patients Medicina Clinica 111(20): 774-775
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
1999: Autologous bone marrow transplantation for chronic myeloid leukemia Haematologica 84(8): 674
Yano, S. 2011: The role of allogenic hematopoietic stem cell transplantation for chronic myeloid leukemia in imatinib era Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 759-764
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Wächter, M.; Goldschmidt, H.; Blau, W.; Elstner, E.; Ihle, R. 1988: Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro Folia Haematologica 115(6): 927-934
Bee, P.C.; Gan, G.G.; Sangkar, V.J.; Haris, A.R. 2008: Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation Medical Journal of Malaysia 63(1): 71-72
Tomás, J.F.; Peñarrubia, M.J.; García, J.A.; Figuera, A.; Gómez-García de Soria, V.; Steegmann, J.L.; Arranz, R.; Cámara, R.; Gabriel, R.; Vázquez, L. 1995: Allogeneic bone marrow transplantation in chronic myeloid leukemia. the clinical results and risk factors in 70 patients Medicina Clinica 105(16): 605-611
Zikos, P.; Van Lint, M.T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Bregante, S.; Berisso, G.; Mordini, N.; Incagliato, M.; Fugazza, G.; Sessarego, M.; Bacigalupo, A. 1998: Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse Haematologica 83(10): 896-903
Gómez, M.; Urbano-Ispizua, A.; Cervantes, F.; Fernández-Avilés, F.; Rovira, M.; Carreras, E. 2002: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation Haematologica 87(9): 1003-1005
Vinogradova, O.A.; Savchenko, V.G.; Neverova, A.L.; Diachenko, L.V.; Domracheva, E.V.; Liubimova, L.S.; Mendeleeva, L.P. 2001: Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow Terapevticheskii Arkhiv 73(7): 26-34
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Kiyoi, H.; Fukutani, H.; Yamauchi, T.; Kubo, K.; Ohno, R.; Yamamori, S.; Naoe, T. 1995: Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crises after bone marrow transplantation Leukemia 9(2): 265-270